v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2024   331          
Beginning balance at Dec. 31, 2024 $ 8,532 $ 0 $ 5,976 $ 5,982 $ (2,052) $ (2,152) $ 778
Beginning balance, Treasury stock (in shares) at Dec. 31, 2024           56  
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)   0          
Exercise of stock options 4   4        
F&G common stock offering 117   8       109
Other comprehensive earnings - unrealized gain on investments and other financial instruments 267       267    
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates 8 [1]       8    
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation 6 [2]       6    
Reclassification adjustments for change in unrealized gains and losses included in net earnings (2) [3]       (2)    
Change in instrument-specific credit risk - market risk benefits 23 [4]       23    
Change in current discount rate — liability for future policy benefits (86) [5]       (86)    
Stock-based compensation 21   20       1
Shares withheld for taxes and in treasury (2)           (2)
Dilution from share issuance by consolidated sub 0   0        
Repurchases of treasury stock (in shares)           1  
Repurchases of treasury stock (25)         $ (25)  
Dividends declared, per common share (137)     (137)      
Other comprehensive earnings (loss) associated with noncontrolling interests (30) [6]       (30)   30
Subsidiary dividends declared to non-controlling interests (12)           (12)
Net earnings 83     83     0
Ending balance (in shares) at Mar. 31, 2025   331          
Ending balance at Mar. 31, 2025 8,797 $ 0 6,008 5,928 (1,866) $ (2,177) 904
Ending balance, Treasury stock (in shares) at Mar. 31, 2025           57  
Beginning balance (in shares) at Dec. 31, 2025   332          
Beginning balance at Dec. 31, 2025 $ 8,972 $ 0 6,042 5,484 (1,678) $ (2,424) 1,548
Beginning balance, Treasury stock (in shares) at Dec. 31, 2025 61         61  
Increase (Decrease) in Stockholders' Equity              
Other comprehensive earnings - unrealized gain on investments and other financial instruments $ (591)       (591)    
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates [1] 0            
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation (11) [2]       (11)    
Reclassification adjustments for change in unrealized gains and losses included in net earnings 25 [3]       25    
Change in instrument-specific credit risk - market risk benefits 38 [4]       38    
Change in current discount rate — liability for future policy benefits 162 [5]       162    
Stock-based compensation 23   21       2
Repurchases of treasury stock (in shares)           2  
Repurchases of treasury stock (81)         $ (81)  
F&G repurchases of F&G stock (29)   9       (38)
Dividends declared, per common share (141)     (141)      
Other comprehensive earnings (loss) associated with noncontrolling interests 105 [6]       105   (105)
Change in F&G outside tax basis 51   (4)   55    
Subsidiary dividends declared to non-controlling interests (20)           (20)
Net earnings 321     243     78
Ending balance (in shares) at Mar. 31, 2026   332          
Ending balance at Mar. 31, 2026 $ 8,719 $ 0 $ 6,068 $ 5,586 $ (1,895) $ (2,505) $ 1,465
Ending balance, Treasury stock (in shares) at Mar. 31, 2026 63         63  
[1] Net of income tax expense of $2 million for the three months ended March 31, 2025.
[2] Net of income tax (benefit) expense of $(3) million and $1 million for the three months ended March 31, 2026 and 2025, respectively.
[3] Net of income tax expense of $6 million for the three months ended March 31, 2026.
[4] Net of income tax expense of $10 million and $6 million for the three months ended March 31, 2026 and 2025, respectively.
[5] Net of income tax expense (benefit) of $43 million and $(21) million for the three months ended March 31, 2026 and 2025, respectively.
[6] Net of income tax expense (benefit) of $29 million and $(8) million for the three months ended March 31, 2026 and 2025, respectively.